Yuhan Corp. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
86,461
90,948
126,047
161,249
109,637
58,335
Depreciation, Depletion & Amortization
18,903
26,513
31,056
42,920
52,195
59,000
Other Funds
-
-
-
-
201
35,258
Funds from Operations
112,481
148,828
163,079
182,930
171,559
152,593
Changes in Working Capital
32,703
54,442
36,845
108,786
45,434
59,142
Net Operating Cash Flow
79,778
94,386
126,235
74,144
126,125
93,452
Capital Expenditures
59,534
38,442
83,275
84,625
59,911
Sale of Fixed Assets & Businesses
808
536
999
120
142
Purchase/Sale of Investments
47,890
154,343
35,517
6,548
15,983
Net Investing Cash Flow
10,579
192,249
117,793
77,141
42,241
Cash Dividends Paid - Total
13,198
15,629
18,038
20,546
20,546
Issuance/Reduction of Debt, Net
44,000
18,100
81,400
45,000
66,617
Net Financing Cash Flow
5,711
16,390
57,388
23,295
68,173
Net Change in Cash
74,948
114,270
66,125
23,049
11,753
Free Cash Flow
24,017
58,547
44,973
5,932
69,353
Other Sources
257
-
-
816
1,629
Change in Capital Stock
25,091
18,861
5,974
1,159
19,191
Exchange Rate Effect
38
16
295
2,751
3,958
Other Uses
-
-
-
-
85

About Yuhan

View Profile
Address
Yuhan Building
Seoul SL 06927
Korea, Republic Of
Employees -
Website http://www.yuhan.co.kr
Updated 07/08/2019
Yuhan Corp. engages in the manufacture of pharmaceutical, health foods, cosmetics and consumer products. It operates through the following business areas: Pharmaceutical, Household products and Active Pharmaceutical Ingredient (API). Its products include APIs and intermediates and finished products such as ethical drugs, over-the-counter drugs and others.